Novartis presence in Indonesia
Novartis history in Indonesia began already in 1968 through the incorporation of PT Ciba Indonesia. After undergoing several milestones, following the global merger of Sandoz and Ciba Geigy to create Novartis, PT Ciba Indonesia merged with PT Sandoz Biochemie Pharma to become PT Novartis Biochemie in 1996.
In 2005, following Novartis global acquisition of Hexal Group, Novartis Indonesia's Sandoz Division also acquired PT Prima Hexal in Indonesia and hence established an enlarged new legal entity called PT Sandoz Indonesia.
In 2006, PT Novartis Biochemie change its legal entity to become PT Novartis Indonesia and celebrate its 10 years merger worldwide.
Today, Novartis in Indonesia employs about 650 employees in its Pharmaceutical and Consumer Health division. The company also has a research laboratory, NITD Hasanuddin University Research Institute (NHCRI) in Makassar, Sulawesi which focuses in developing drugs for tropical diseases such as Dengue, Tuberculosis and Malaria.
Novartis other 2 sister companies, PT Ciba Vision Batam is a global supply chain hub for Ciba Vision contact lenses and contracts 3000 associates at its plant in Pulau Batam. PT Sandoz Indonesia runs the Generic medicines Division and employs 600 employeeslocated in Pasar Rebo, Jakarta.
PT Sandoz Indonesia runs the Generic medicines Division and employs 600 employees and also operates a plant in Bandung, West Java.